Reditrex

Active Ingredient(s): Methotrexate
FDA Approved: * November 27, 2019
Pharm Company: * CUMBERLAND PHARMS
Category: Cancer

* This drug may consist of multiple approval dates, manufacturers, or distributors. If applicable, they would be listed below under "NDC Database Records".



Reditrex Overview

Methotrexate (MTX), formerly known as amethopterin, is a chemotherapy agent and immune system suppressant.[4] It is used to treat cancer, autoimmune diseases, ectopic pregnancy, and for medical abortions.[4] Types of cancers it is used for include breast cancer, leukemia, lung cancer, lymphoma, gestational trophoblastic disease, and osteosarcoma.[4] Types of autoimmune diseases it is used for include psoriasis, rheumatoid arthritis, and Crohn's ...

Read more Reditrex Details
Details May Include Instructions, Side Effects, Interactions, Etc. Drug monograph is from Wikipedia. All text is available under the terms of the GFDL (GNU Free Documentation License). Source: en.wikipedia.org/wiki/Methotrexate

Recent Reditrex Forums:

Be the first to start a discussion about this drug.

Possible Dosages for this and Related Drugs:

Methotrexate
  • Injection: 10 Mg/0.4 Ml, 15 Mg/0.4 Ml, 20 Mg/0.4 Ml And 25mg/0.4 Ml, 1000mg, 100mg/4ml (25mg/ml), 100mg/vial, 10mg/0.20ml, 12.5mg/0.25ml, 15mg/0.30ml, 17.5mg/0.35ml, 1g, 1gm/40ml (25 mg/ml), 1gm/40ml (25mg/ml), 1gm/vial, 2.5gm/100ml (25 mg/ml), 2.5gm/100ml (25mg/ml), 2.5mg/ml, 200mg/8ml (25mg/ml), 20mg, 20mg/0.4ml, 20mg/2ml (10 mg/ml), 20mg/2ml (10mg/ml), 20mg/vial, 22.5mg/0.45ml, 250mg/10ml (25mg/ml), 25mg/0.50ml, 25mg/ml, 27.5mg/0.55ml, 30mg/0.60ml, 500mg/20ml (25 mg/ml), 500mg/20ml (25mg/ml), 50mg/2ml (25 mg/ml), 50mg/2ml (25mg/ml), 50mg/vial, 5g/50ml, 7.5mg/0.15ml
  • Powder: 100%
  • Solution: 10mg/0.20ml, 10mg/0.20ml (10mg/0.20ml), 10mg/0.4ml, 10mg/0.4ml (10mg/0.4ml), 12.5mg/0.25ml, 12.5mg/0.25ml (12.5mg/0.25ml), 12.5mg/0.4ml (12.5mg/0.4ml), 12.5mg/0.5ml (12.5mg/0.5ml), 15mg/0.30ml, 15mg/0.30ml (15mg/0.30ml), 15mg/0.4ml, 15mg/0.4ml (15mg/0.4ml), 15mg/0.6ml (15mg/0.6ml), 17.5mg/0.35ml, 17.5mg/0.35ml (17.5mg/0.35ml), 17.5mg/0.4ml (17.5mg/0.4ml), 17.5mg/0.7ml (17.5mg/0.7ml), 2.5mg/ml, 20mg/0.4ml, 20mg/0.4ml (20mg/0.4ml), 20mg/0.8ml (20mg/0.8ml), 22.5mg/0.45ml, 22.5mg/0.45ml (22.5mg/0.45ml), 22.5mg/0.4ml (22.5mg/0.4ml), 22.5mg/0.9ml (22.5mg/0.9ml), 22.5mg/ml (22.5mg/ml), 25mg/0.4ml, 25mg/0.4ml (25mg/0.4ml), 25mg/0.5ml, 25mg/0.5ml (25mg/0.5ml), 25mg/1ml (25mg/1ml), 25mg/ml (25mg/ml), 27.5mg/0.55ml, 27.5mg/0.55ml (27.5mg/0.55ml), 2mg/ml, 30mg/0.6ml, 30mg/0.6ml (30mg/0.6ml), 5gm/50ml (100mg/ml), 7.5mg/0.15ml, 7.5mg/0.15ml (7.5mg/0.15ml), 7.5mg/0.3ml (7.5mg/0.3ml), 7.5mg/0.4ml, 7.5mg/0.4ml (7.5mg/0.4ml)
  • Tablet: 10mg, 15mg, 2.5mg, 5mg, 7.5mg
Note: Above list includes dosages for all drugs with the same combination of active ingredients.

NDC Database Records for Reditrex: (8 results)

Sorted by National Drug Code
  • 66220-807 Reditrex 7.5 mg/.3ml Subcutaneous Injection, Solution by Cumberland Pharmaceuticals Inc.
  • 66220-810 Reditrex 10 mg/.4ml Subcutaneous Injection, Solution by Cumberland Pharmaceuticals Inc.
  • 66220-812 Reditrex 12.5 mg/.5ml Subcutaneous Injection, Solution by Cumberland Pharmaceuticals Inc.
  • 66220-815 Reditrex 15 mg/.6ml Subcutaneous Injection, Solution by Cumberland Pharmaceuticals Inc.
  • 66220-817 Reditrex 17.5 mg/.7ml Subcutaneous Injection, Solution by Cumberland Pharmaceuticals Inc.
  • 66220-820 Reditrex 20 mg/.8ml Subcutaneous Injection, Solution by Cumberland Pharmaceuticals Inc.
  • 66220-822 Reditrex 22.5 mg/.9ml Subcutaneous Injection, Solution by Cumberland Pharmaceuticals Inc.
  • 66220-825 Reditrex 25 mg/ml Subcutaneous Injection, Solution by Cumberland Pharmaceuticals Inc.

Other drugs which contain Methotrexate or a similar ingredient: (9 results)




Note: All times displayed are GMT - 7.

This information has been independently compiled and is for informational purposes only. It is not intended to be a substitute for medical advice from a qualified healthcare professional; nor is it intended to diagnose, treat, cure or prevent any disease. For more details please see the Medical Disclaimer. This page was last updated on 24 October 2020.

We are committed to your privacy.

Copyright © 2005-2020 All Rights Reserved. MedsChat® is a registered trademark of Limelight Innovations L.L.C. 9888 W Belleview Ave #5000, Denver, CO, 80123, USA